<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fletcher P</submitter><funding>National Institute of Environmental Health Sciences</funding><funding>NIEHS NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>359-373</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8127607</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>70(3)</volume><pubmed_abstract>&lt;h4>Objective and design&lt;/h4>The omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) has been reported to suppress inflammation. Pulmonary inflammation can be directly linked to exposure of various occupational and man-made particles leading to pulmonary diseases. Therapeutic treatments are lacking for particle-induced pulmonary inflammation. These studies evaluated DHA as a therapeutic treatment for semi-acute and chronic particle-induced pulmonary inflammation.&lt;h4>Methods&lt;/h4>Balb/c mice were oropharyngeal instilled with hydrophobic multi-walled carbon nanotube (MWCNT) or hydrophilic crystalline silica (SiO&lt;sub>2&lt;/sub>) either as one instillation (semi-acute) or once a week for 4 weeks (chronic). One week later, the mice were placed on either a control or 1% DHA-containing diet</pubmed_abstract><journal>Inflammation research : official journal of the European Histamine Research Society ... [et al.]</journal><pubmed_title>Therapeutic treatment of dietary docosahexaenoic acid for particle-induced pulmonary inflammation in Balb/c mice.</pubmed_title><pmcid>PMC8127607</pmcid><funding_grant_id>R01 ES023209</funding_grant_id><funding_grant_id>R01 ES027353</funding_grant_id><funding_grant_id>F31 ES028100</funding_grant_id><funding_grant_id>P30 GM103338</funding_grant_id><pubmed_authors>Fletcher P</pubmed_authors><pubmed_authors>Rhoderick JF</pubmed_authors><pubmed_authors>Postma B</pubmed_authors><pubmed_authors>Holian A</pubmed_authors><pubmed_authors>Pestka JJ</pubmed_authors><pubmed_authors>Buford M</pubmed_authors><pubmed_authors>Hamilton RF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Therapeutic treatment of dietary docosahexaenoic acid for particle-induced pulmonary inflammation in Balb/c mice.</name><description>&lt;h4>Objective and design&lt;/h4>The omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) has been reported to suppress inflammation. Pulmonary inflammation can be directly linked to exposure of various occupational and man-made particles leading to pulmonary diseases. Therapeutic treatments are lacking for particle-induced pulmonary inflammation. These studies evaluated DHA as a therapeutic treatment for semi-acute and chronic particle-induced pulmonary inflammation.&lt;h4>Methods&lt;/h4>Balb/c mice were oropharyngeal instilled with hydrophobic multi-walled carbon nanotube (MWCNT) or hydrophilic crystalline silica (SiO&lt;sub>2&lt;/sub>) either as one instillation (semi-acute) or once a week for 4 weeks (chronic). One week later, the mice were placed on either a control or 1% DHA-containing diet</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-04T10:16:18.895Z</modification><creation>2025-04-04T10:16:18.895Z</creation></dates><accession>S-EPMC8127607</accession><cross_references><pubmed>33566171</pubmed><doi>10.1007/s00011-021-01443-4</doi></cross_references></HashMap>